Evaluating the Market for Contract API Manufacturing
Source: www.pharmtech.com
Contract API manufacturers and fine-chemical producers roll out capacity and service expansions. Contract API manufacturers and fine-chemical producers gathered at Informex, the annual trade show of custom and batch manufacturers, in New Orleans in February. MORE
More information on API manufacturers? Find here
Round-up of CMO news
Source: www.outsourcing-pharma.com
Contract manufacturing organisations (CMOs) have been busy in the past week, with OsoBio expanding its plant and AMRI adopting a new relationship strategy.” MORE
List of Contract Manufacturers? Find here
Manufacturers Wrestle with Drug Abuse and Critical Shortages
Source: www.biopharminternational.com
Soaring opioid use creates challenges for new drug development and supply-chain control. The United States is caught in an epidemic of prescription-drug overuse and abuse, and federal enforcers are revving up forces to counter illegal diversion of approved drugs. MORE
Looking for Contract Manufacturers? Find here
Partnering with Potency - Requirements for outsourcing high containment development activities
Source: www.contractpharma.com
Cancer is a leading cause of death worldwide, and the development of more effective, efficient and targeted cancer treatments is both critical and urgent. High potency active pharmaceutical ingredients (HPAPIs) have characteristics that allow the selective targeting of cancer cells, blocking their growth while causing less harm to normal cells. MORE
More information on HPAPI providers? Find here
Parenteral Outsourcing Trends - More opportunities, but greater regulatory scrutiny
Source: www.contractpharma.com
To get ready for this year’s Parenteral Drug Association annual meeting, we spoke with a number of parenteral CMOs to gauge the state of the business, the key drivers, and how the increased regulatory burden affects operations. MORE
More information on parenteral providers? Find here
The Pulse of Pharmaceutical Manufacturing
Source: www.pharmamanufacturing.com
The big picture has changed very little in ten years. While pointing out root causes, observers also see reasons for optimism. During the past decade, pharmaceutical manufacturing and quality functions were thrust into an unaccustomed spotlight. After an extended spate of consent decrees, noncompliance and drug quality problems, FDA began to look for root causes and to consider lessons in manufacturing science that regulators and manufacturers might learn from other industries. MORE
List of Contract Manufacturers? Find here
